FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013383695> ?p ?o ?g. }

• W2013383695 endingPage "11691" @default.
• W2013383695 startingPage "11679" @default.
• W2013383695 abstract "In this study, we investigated the mechanism of the loss or decreased expression of β2-microglobulin (β2m) in several drug-resistant sublines of MCF-7 and in a doxorubicin (DOX)-resistant variant of the T-47D breast cancer cell line. β2m protein and RNA are not expressed in highly metastatic, multidrug-resistant MCF-7/Adr cells with high resistance to DOX. Nuclear run-on transcription and RNA stability assays demonstrate that while β2m in MCF-7/Adr cells is transcribed, its mRNA is rapidly degraded after synthesis in these cells, indicating that it is controlled by post-transcriptional mechanisms. We also show that an MCF-7 subline (MCF-7/Adr-5) expressing a very low level of resistance to DOX has a decreased level of β2m expression. Treatment with actinomycin D revealed that the half-life of β2m mRNA in MCF-7 and MCF-7/Adr-5 cell lines was comparable. Nuclear run-on transcription analysis revealed a decreased rate of β2m transcription in MCF-7/Adr-5 cells compared to that in MCF-7 cells. Moreover, β2m mRNA remained undetectable in MCF-7/Adr cells following cycloheximide treatment. However, in MCF-7 cells, increased β2m mRNA was observed after 12 h, and a similar level of increased mRNA expression was observed after 36 h of cycloheximide treatment in MCF-7/Adr-5 cells; these results suggest that one of the mechanisms controlling β2m mRNA expression might be a negative regulatory protein in MCF-7/Adr-5 cells. Analysis of the β2m status of other drug-resistant MCF-7 sublines revealed that deregulation of β2m is not limited to DOX resistance, but can also be detected in cells selected for resistance to mAMSA and DOX-verapamil. In addition, our data show that reduced β2m expression correlates with the decreased levels of estrogen receptor (ER) expression in the DOX-resistant MCF-7/Adr and T-47D/Adr-4 human breast cell lines. Furthermore, we provide evidence that the partial inhibition of β2m by antisense RNA results in 2−3-fold decreased sensitivity of MCF-7 cells to DOX and mAMSA. Moreover, the addition of exogenous β2m protein near its physiological human serum concentration can modulate the DOX sensitivity of the MCF-7 antisense β2m and control transfectants. Therefore, these results indicate that lost or decreased β2m expression is involved in the development of the drug-resistant phenotype and correlates with the loss of ER in human breast cancer cell lines." @default.
• W2013383695 created "2016-06-24" @default.
• W2013383695 creator A5011733159 @default.
• W2013383695 creator A5018886688 @default.
• W2013383695 creator A5089497343 @default.
• W2013383695 date "1998-07-21" @default.
• W2013383695 modified "2023-09-23" @default.
• W2013383695 title "Molecular Mechanisms of Loss of β₂-Microglobulin Expression in Drug-Resistant Breast Cancer Sublines and Its Involvement in Drug Resistance" @default.
• W2013383695 cites W1534762642 @default.
• W2013383695 cites W1542447612 @default.
• W2013383695 cites W1602709607 @default.
• W2013383695 cites W1608671886 @default.
• W2013383695 cites W1989700374 @default.
• W2013383695 cites W2054694895 @default.
• W2013383695 cites W2129528803 @default.
• W2013383695 cites W2135808990 @default.
• W2013383695 cites W2152104067 @default.
• W2013383695 cites W2154298769 @default.
• W2013383695 cites W2156032604 @default.
• W2013383695 cites W2398521772 @default.
• W2013383695 doi "https://doi.org/10.1021/bi980573c" @default.
• W2013383695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9709006" @default.
• W2013383695 hasPublicationYear "1998" @default.
• W2013383695 type Work @default.
• W2013383695 sameAs 2013383695 @default.
• W2013383695 citedByCount "30" @default.
• W2013383695 countsByYear W20133836952013 @default.
• W2013383695 countsByYear W20133836952014 @default.
• W2013383695 countsByYear W20133836952017 @default.
• W2013383695 countsByYear W20133836952018 @default.
• W2013383695 countsByYear W20133836952019 @default.
• W2013383695 countsByYear W20133836952021 @default.
• W2013383695 crossrefType "journal-article" @default.
• W2013383695 hasAuthorship W2013383695A5011733159 @default.
• W2013383695 hasAuthorship W2013383695A5018886688 @default.
• W2013383695 hasAuthorship W2013383695A5089497343 @default.
• W2013383695 hasConcept C104317684 @default.
• W2013383695 hasConcept C105580179 @default.
• W2013383695 hasConcept C109541995 @default.
• W2013383695 hasConcept C114851261 @default.
• W2013383695 hasConcept C121608353 @default.
• W2013383695 hasConcept C133936738 @default.
• W2013383695 hasConcept C138885662 @default.
• W2013383695 hasConcept C150194340 @default.
• W2013383695 hasConcept C153911025 @default.
• W2013383695 hasConcept C179926584 @default.
• W2013383695 hasConcept C2776694085 @default.
• W2013383695 hasConcept C2778128677 @default.
• W2013383695 hasConcept C2781303535 @default.
• W2013383695 hasConcept C2994423619 @default.
• W2013383695 hasConcept C3675279 @default.
• W2013383695 hasConcept C41895202 @default.
• W2013383695 hasConcept C502942594 @default.
• W2013383695 hasConcept C54355233 @default.
• W2013383695 hasConcept C55493867 @default.
• W2013383695 hasConcept C67705224 @default.
• W2013383695 hasConcept C81885089 @default.
• W2013383695 hasConcept C86803240 @default.
• W2013383695 hasConcept C96232424 @default.
• W2013383695 hasConceptScore W2013383695C104317684 @default.
• W2013383695 hasConceptScore W2013383695C105580179 @default.
• W2013383695 hasConceptScore W2013383695C109541995 @default.
• W2013383695 hasConceptScore W2013383695C114851261 @default.
• W2013383695 hasConceptScore W2013383695C121608353 @default.
• W2013383695 hasConceptScore W2013383695C133936738 @default.
• W2013383695 hasConceptScore W2013383695C138885662 @default.
• W2013383695 hasConceptScore W2013383695C150194340 @default.
• W2013383695 hasConceptScore W2013383695C153911025 @default.
• W2013383695 hasConceptScore W2013383695C179926584 @default.
• W2013383695 hasConceptScore W2013383695C2776694085 @default.
• W2013383695 hasConceptScore W2013383695C2778128677 @default.
• W2013383695 hasConceptScore W2013383695C2781303535 @default.
• W2013383695 hasConceptScore W2013383695C2994423619 @default.
• W2013383695 hasConceptScore W2013383695C3675279 @default.
• W2013383695 hasConceptScore W2013383695C41895202 @default.
• W2013383695 hasConceptScore W2013383695C502942594 @default.
• W2013383695 hasConceptScore W2013383695C54355233 @default.
• W2013383695 hasConceptScore W2013383695C55493867 @default.
• W2013383695 hasConceptScore W2013383695C67705224 @default.
• W2013383695 hasConceptScore W2013383695C81885089 @default.
• W2013383695 hasConceptScore W2013383695C86803240 @default.
• W2013383695 hasConceptScore W2013383695C96232424 @default.
• W2013383695 hasIssue "33" @default.
• W2013383695 hasLocation W20133836951 @default.
• W2013383695 hasLocation W20133836952 @default.
• W2013383695 hasOpenAccess W2013383695 @default.
• W2013383695 hasPrimaryLocation W20133836951 @default.
• W2013383695 hasRelatedWork W1543072402 @default.
• W2013383695 hasRelatedWork W2025926160 @default.
• W2013383695 hasRelatedWork W2027265530 @default.
• W2013383695 hasRelatedWork W2092502122 @default.
• W2013383695 hasRelatedWork W2116526157 @default.
• W2013383695 hasRelatedWork W2169245481 @default.
• W2013383695 hasRelatedWork W2313211238 @default.
• W2013383695 hasRelatedWork W2415441743 @default.
• W2013383695 hasRelatedWork W2418698132 @default.
• W2013383695 hasRelatedWork W4246806260 @default.
• W2013383695 hasVolume "37" @default.

• next